Good afternoon and welcome to Markets Desk, your midday read on the stories moving markets right now.
Oil is trading lower today despite Treasury Secretary Bessent signaling what he called an economic D-Day announcement tied to new Iran sanctions. The market's hesitation is telling — traders are watching closely how any expanded sanctions would affect China, which absorbs the lion's share of Iranian crude and could face significant supply disruptions or diplomatic friction if Washington moves aggressively.
Shifting to healthcare, the FDA has cleared a new Alzheimer's blood test developed jointly by Roche and Eli Lilly. The test is described as minimally invasive and is designed to help physicians detect the biological markers of Alzheimer's earlier than current diagnostic tools allow. That early detection window could meaningfully change treatment timelines, and both stocks are drawing attention from the biotech and pharma community as a result.
And in media, California Attorney General Rob Bonta has pulled out of a scheduled settlement meeting with Paramount, citing what he called a lack of good faith on the company's part. That's a significant escalation in what was already a closely watched regulatory standoff, and it raises fresh questions about the path forward for any deal Paramount may be pursuing that requires state-level sign-off.
That's the tape. Markets Desk, signing off the floor.
